Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Trade Show, Webcast

Novus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment Conferences


Novus Therapeutics, Inc. ("Novus") (NASDAQ: NVUS), a clinical stage biotechnology company targeting the CD40L pathway to develop potential treatments for organ or cell-based transplant, autoimmune and neurodegenerative diseases, today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will present a corporate overview to virtual audiences this week at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference and at the Cantor Virtual Global Healthcare Conference.

Conferences Details

Event:

 

H.C. Wainwright 22nd Annual Global Investment Conference (virtual)

Date:

 

Wednesday, September 16th

Time:

 

3:30 p.m. ET

 

 

 

Event:

 

Cantor Virtual Global Healthcare Conference (virtual)

Date:

 

Thursday, September 17th

Time:

 

12:00 p.m. ET

Live webcasts of both presentations can be accessed by visiting the "Events and Presentations" tab of the investor section of the Novus website at http://ir.novustherapeutics.com/events-and-presentations/events. A replay of the webcasts will be archived for 30 days following the conference.

About Novus Therapeutics

Novus Therapeutics, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Novus is headquartered in Irvine, Calif. For more information, please visit the company's website at www.novustherapeutics.com. Follow Novus Therapeutics on social media: @Novus_Thera and LinkedIn.

Forward-Looking Statements

This press release contains forward?looking statements that involves substantial risks and uncertainties. Any statements about the company's future expectations, plans and prospects, including statements about its strategy, future operations, development of its product candidates, and other statements containing the words "believes," "anticipates," "plans," "expects," "estimates," "intends," "predicts," "projects," "targets," "looks forward," "could," "may," and similar expressions, constitute forward?looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, although not all forward?looking statements include such identifying words. Forward?looking statements include, but are not limited to statements regarding: risks related to market conditions; expectations regarding the timing for the commencement of future clinical trials; expectations regarding the success of clinical trials; the rate and degree of market acceptance and clinical utility of the company's products; the company's estimates regarding expenses and cash runway; and the impact of the ongoing coronavirus pandemic. Actual results may differ materially from those indicated by such forward?looking statements as a result of various factors. These risks and uncertainties, as well as other risks and uncertainties that could cause the company's actual results to differ significantly from the forward?looking statements contained herein, are discussed in our quarterly 10-Q, annual 10-K, and other filings with the SEC, which can be found at www.sec.gov. Any forward?looking statements contained in this press release speak only as of the date hereof and not of any future date, and the company expressly disclaims any intent to update any forward?looking statements, whether as a result of new information, future events or otherwise.


These press releases may also interest you

at 06:45
The "Global Telemedicine Services and Equipment Market" report has been added to ResearchAndMarkets.com's offering. Global telemedicine market can be estimated at the level of USD 60.2 billion in 2019 and is expected to exceed USD 162 billion by...

at 06:35
The global synthetic zeolite market size is expected to grow by USD 346.39 million during 2020-2024, progressing at a CAGR of almost 4% during the forecast period. Download latest version with COVID-19 analysis Free Sample Report The demand from...

at 06:35
Graham Corporation , a global business that designs, manufactures and sells critical equipment for the oil refining, petrochemical and defense industries, today reported financial results for its second quarter ended September 30, 2020. Graham's...

at 06:35
Civeo Corporation today reported financial and operating results for the third quarter ended September 30, 2020. Highlights include: Reported third quarter revenues of $142.9 million, net income of $6.5 million and operating cash flow of $35.4...

at 06:35
Applied Industrial Technologies , a leading value-added distributor and technical solutions provider of industrial motion, fluid power, flow control, automation technologies, and related maintenance supplies, today reported results for its fiscal...

at 06:35
Regulatory News: NICE inContact, a NICE business , today introduced CXone Performance Analytics integrated with Salesforce Einstein, an AI-powered analytics application that uncovers new contact center performance insights by analyzing blended...



News published on 15 september 2020 at 17:00 and distributed by: